NO20080468L - Diazepinokinoliner, synteser av disse samt intermediater - Google Patents
Diazepinokinoliner, synteser av disse samt intermediaterInfo
- Publication number
- NO20080468L NO20080468L NO20080468A NO20080468A NO20080468L NO 20080468 L NO20080468 L NO 20080468L NO 20080468 A NO20080468 A NO 20080468A NO 20080468 A NO20080468 A NO 20080468A NO 20080468 L NO20080468 L NO 20080468L
- Authority
- NO
- Norway
- Prior art keywords
- intermediates
- diazepinoquinolines
- syntheses
- agonists
- synthesis
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
- C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
- C07D221/04—Ortho- or peri-condensed ring systems
- C07D221/06—Ring systems of three rings
- C07D221/16—Ring systems of three rings containing carbocyclic rings other than six-membered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/06—Peri-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/06—Peri-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Reproductive Health (AREA)
- Pain & Pain Management (AREA)
- Gynecology & Obstetrics (AREA)
- Endocrinology (AREA)
- Anesthesiology (AREA)
- Dermatology (AREA)
- Hospice & Palliative Care (AREA)
- Obesity (AREA)
- Diabetes (AREA)
- Pregnancy & Childbirth (AREA)
- Addiction (AREA)
- Hematology (AREA)
- Child & Adolescent Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Plural Heterocyclic Compounds (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US70250905P | 2005-07-26 | 2005-07-26 | |
PCT/US2006/028655 WO2007016029A2 (en) | 2005-07-26 | 2006-07-24 | Diazepinoquinolines, synthesis thereof, and intermediates thereto |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20080468L true NO20080468L (no) | 2008-02-22 |
Family
ID=37603396
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20080468A NO20080468L (no) | 2005-07-26 | 2008-01-25 | Diazepinokinoliner, synteser av disse samt intermediater |
Country Status (20)
Country | Link |
---|---|
US (1) | US7671196B2 (es) |
EP (1) | EP1907390A2 (es) |
JP (1) | JP2009502925A (es) |
KR (1) | KR20080030682A (es) |
CN (1) | CN101268076A (es) |
AR (1) | AR054849A1 (es) |
AU (1) | AU2006276010A1 (es) |
BR (1) | BRPI0614154A2 (es) |
CA (1) | CA2616161A1 (es) |
CR (1) | CR9670A (es) |
EC (1) | ECSP088151A (es) |
GT (1) | GT200600326A (es) |
IL (1) | IL188896A0 (es) |
MX (1) | MX2008001030A (es) |
NO (1) | NO20080468L (es) |
PE (1) | PE20070238A1 (es) |
RU (1) | RU2008102884A (es) |
SA (1) | SA06270241B1 (es) |
TW (1) | TW200738713A (es) |
WO (1) | WO2007016029A2 (es) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GT200500317A (es) * | 2004-11-05 | 2006-10-27 | Proceso para preparar compuestos de quinolina y productos obtenidos de los mismos | |
AR054849A1 (es) | 2005-07-26 | 2007-07-18 | Wyeth Corp | Diazepinoquinolinas, sintesis de las mismas, e intermediarios para obtenerlas |
TW200734334A (en) * | 2006-01-13 | 2007-09-16 | Wyeth Corp | Treatment of substance abuse |
BRPI0709146A2 (pt) * | 2006-03-24 | 2011-06-28 | Wyeth Corp | métodos para tratar distúrbios cognitivos e outros distúrbios |
CA2645099A1 (en) * | 2006-03-24 | 2007-10-04 | Wyeth | Methods for modulating bladder function |
KR20080110759A (ko) * | 2006-03-24 | 2008-12-19 | 와이어쓰 | 통증 치료 |
BRPI0709159A2 (pt) * | 2006-03-24 | 2011-06-28 | Wyeth Corp | combinações terapêuticas para o tratamento de depressão |
CL2008002777A1 (es) * | 2007-09-21 | 2010-01-22 | Wyeth Corp | Metodo de preparacion de compuestos diazepinoquinolinicos quirales por recristalizacion en un sistema de solvente ternario. |
CN103204858A (zh) * | 2013-03-20 | 2013-07-17 | 广州科瑞生物技术有限公司 | 基于酒石酸拆分合成工艺制备新型手性抗焦虑症药物 |
Family Cites Families (87)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3158619A (en) | 1962-06-14 | 1964-11-24 | Searle & Co | Certain sulfur-containing ortho-fused polycyclic pyrazole derivatives |
US3235564A (en) | 1964-03-27 | 1966-02-15 | Searle & Co | Intermediates to certain sulfur-containing ortho-fused polycyclic pyrazole derivatives |
US3296252A (en) | 1964-04-02 | 1967-01-03 | Sandoz Ag | Tetracyclic diazepinone compounds |
US3335134A (en) | 1964-04-02 | 1967-08-08 | Sandoz Ag | Certain 3, 4-dihydrofluoreno[1, 9a, 9-e, f]1, 4-diazepin-3(2h)-ones |
GB1120462A (en) | 1964-07-06 | 1968-07-17 | Manuf Prod Pharma | 3-alkoxy-2h-fluoreno[1,9-ef]-1,4-diazepine 1-oxides and derivatives thereof |
US3417101A (en) | 1964-11-09 | 1968-12-17 | American Home Prod | Fused ring compounds |
US3329676A (en) | 1964-11-09 | 1967-07-04 | American Home Prod | Fused 1, 4-diazepine ring systems |
US3714149A (en) | 1969-11-03 | 1973-01-30 | Upjohn Co | Pyridobenzodiazepinones |
US3914250A (en) | 1974-08-01 | 1975-10-21 | American Home Prod | 1,4-Diazepino{8 6,5,4-jk{9 carbazoles |
SU930902A1 (ru) | 1980-12-18 | 1982-10-15 | Всесоюзный научно-исследовательский химико-фармацевтический институт им.Серго Орджоникидзе | Производные тиено [3,2=в] индола |
US4880814A (en) | 1987-11-13 | 1989-11-14 | Abbott Laboratories | 7-cycloalkyl naphthyridines |
US4948897A (en) | 1987-12-11 | 1990-08-14 | Jet Research Center, Inc. | Method of preparation of 2,6-bis(picrylamino)-3,5-dinitropyridine |
GB8812636D0 (en) | 1988-05-27 | 1988-06-29 | Glaxo Group Ltd | Chemical compounds |
JPH0240379A (ja) | 1988-07-28 | 1990-02-09 | Wakunaga Pharmaceut Co Ltd | 新規キノロン誘導体 |
EP0357417A1 (en) | 1988-09-01 | 1990-03-07 | Glaxo Group Limited | Lactam derivatives |
JP2955358B2 (ja) | 1989-06-09 | 1999-10-04 | ファルマシア・アンド・アップジョン・カンパニー | 中枢神経系活性を有する複素環系アミン |
KR0166088B1 (ko) | 1990-01-23 | 1999-01-15 | . | 수용해도가 증가된 시클로덱스트린 유도체 및 이의 용도 |
US5376645A (en) | 1990-01-23 | 1994-12-27 | University Of Kansas | Derivatives of cyclodextrins exhibiting enhanced aqueous solubility and the use thereof |
DE4200259A1 (de) | 1992-01-08 | 1993-07-15 | Asta Medica Ag | Neue 1,2,4-triaminobenzol-derivate und verfahren zu deren herstellung |
CN100384825C (zh) | 1994-06-15 | 2008-04-30 | 大塚制药株式会社 | 苯并杂环衍生物 |
SE9500998D0 (sv) | 1995-03-19 | 1995-03-19 | Haakan Wilhelm Wikstroem | New sulfone ester analogues of iso-clozapine and related structures: atypical neuroleptics |
US5565483A (en) | 1995-06-07 | 1996-10-15 | Bristol-Myers Squibb Company | 3-substituted oxindole derivatives as potassium channel modulators |
TW359669B (en) | 1995-12-15 | 1999-06-01 | Otsuka Pharma Co Ltd | Benzazepine derivatives |
JPH10237073A (ja) | 1996-02-02 | 1998-09-08 | Sumitomo Pharmaceut Co Ltd | 新規な置換グアニジン誘導体およびその製法 |
CA2195697A1 (en) | 1996-02-02 | 1997-08-03 | Masahumi Kitano | Novel substituted guanidine derivatives, process for production thereof, and pharmaceutical uses thereof |
JP2000505451A (ja) | 1996-02-21 | 2000-05-09 | ダーウィン・ディスカバリー・リミテッド | キノロン類およびこれらの治療的使用 |
AU710825B2 (en) | 1996-02-21 | 1999-09-30 | Darwin Discovery Limited | Quinolones and their therapeutic use |
GB9711643D0 (en) | 1997-06-05 | 1997-07-30 | Janssen Pharmaceutica Nv | Glass thermoplastic systems |
US6194407B1 (en) | 1997-07-30 | 2001-02-27 | American Home Products Corporation | Tricyclic pyrido vasopressin agonists |
US6031098A (en) | 1997-08-11 | 2000-02-29 | California Institute Of Technology | Detection and treatment of duplex polynucleotide damage |
DE19806348A1 (de) | 1998-02-12 | 1999-08-19 | Schering Ag | 3,4-Dihydrochinolin-Derivate und ihre Verwendung in Arzneimitteln |
WO1999067219A1 (en) | 1998-06-22 | 1999-12-29 | Elan Pharmaceuticals, Inc. | Compounds for inhibiting beta-amyloid peptide release and/or its synthesis |
AU4710499A (en) | 1998-06-22 | 2000-01-10 | Elan Pharmaceuticals, Inc. | Cyclic amino acid compounds, pharmaceutical compositions comprising same, and methods for inhibiting beta-amyloid peptide release and/or its synthesis by use ofsuch compounds |
US6090803A (en) | 1998-07-24 | 2000-07-18 | American Home Products Corporation | Tricyclic vasopressin agonists |
CO5210925A1 (es) | 1998-11-17 | 2002-10-30 | Novartis Ag | Derivados de diamino nitroguanidina tetrasustituidos |
JP2002532504A (ja) | 1998-12-17 | 2002-10-02 | アメリカン・ホーム・プロダクツ・コーポレイション | 5−ht2c作動薬である2,3,4,4a−テトラヒドロ−1h−ピラジノ(1,2−a)キノキサリン−5(6h)−オン誘導体 |
US6455564B1 (en) | 1999-01-06 | 2002-09-24 | Pharmacia & Upjohn Company | Method of treating sexual disturbances |
AR023574A1 (es) | 1999-04-23 | 2002-09-04 | Pharmacia & Upjohn Co Llc | Compuestos de azepinindol tetraciclico,composiciones farmaceuticas y el uso de dichos compuestos para preparar un medicamento, e intermediarios |
CA2374898C (en) | 1999-05-21 | 2009-12-08 | Biovitrum Ab | Pyrazinyl-piperazine compounds, their use and preparation |
US6465467B1 (en) | 1999-05-21 | 2002-10-15 | Biovitrum Ab | Certain aryl-aliphatic and heteroaryl-aliphatic piperazinyl pyrazines and their use in the treatment of serotonin-related diseases |
DE60014370T2 (de) | 1999-06-15 | 2006-02-09 | Bristol-Myers Squibb Pharma Co., Wilmington | Substituierte heterocyclylkondensierte gamma carboline |
GB9918965D0 (en) | 1999-08-11 | 1999-10-13 | Cerebrus Ltd | Chemical compounds xxi |
GB9918962D0 (en) | 1999-08-11 | 1999-10-13 | Cerebrus Ltd | Chemical compounds xxii |
JP2001089461A (ja) | 1999-09-24 | 2001-04-03 | Konica Corp | テトラヒドロナフトジアゼピン類の製造方法及びスクアリリウム染料の製造方法 |
JP2003525252A (ja) | 2000-02-29 | 2003-08-26 | ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ | Her2抗体とのファルネシルタンパク質トランスフェラーゼ阻害剤組み合わせ剤 |
JP2001244249A (ja) * | 2000-03-01 | 2001-09-07 | Speedfam Co Ltd | 局部エッチング装置の放電管及びテーパ型放電管を用いた局部エッチング装置 |
US6410583B1 (en) | 2000-07-25 | 2002-06-25 | Merck Frosst Canada & Co. | Cyclopentanoindoles, compositions containing such compounds and methods of treatment |
US6784172B2 (en) | 2000-11-03 | 2004-08-31 | Wyeth | Processes for preparation of cyclopenta[b][1,4]diazepino[6,7,1-hi]indoles and derivatives |
AR031202A1 (es) | 2000-11-03 | 2003-09-10 | Wyeth Corp | Ciclopenta(b) (1,4)diazepino(6,7,1-hi) indoles y derivados |
AR031199A1 (es) | 2000-11-03 | 2003-09-10 | Wyeth Corp | Ciclohepta/b//1,4/diacepino/6,7,1-hi/indoles y derivados |
AR031197A1 (es) | 2000-11-03 | 2003-09-10 | Wyeth Corp | Procedimiento para la preparacion de derivados de 1,2,3,4,8,9,10,10a-octahidro-7bh-ciclopenta(b) diazepino(6,7,1-hi)indol |
AR031200A1 (es) | 2000-11-03 | 2003-09-10 | Wyeth Corp | Cicloocta [b] [1,4] diazepino [6,7,1-hi] indoles y derivados |
AR031201A1 (es) | 2000-11-03 | 2003-09-10 | Wyeth Corp | /1,4/diazepino/6,7,1-jk/carbazoles y derivados |
AR031195A1 (es) | 2000-11-03 | 2003-09-10 | Wyeth Corp | Procedimiento para la preparacion de derivados de 1,2,3,4,8,9,10,10a-octahidro-7bh-ciclopenta (b) (1,4) diazepino (6,7,1) diazepino (6,7,1-hi) indol |
WO2002036596A2 (en) | 2000-11-03 | 2002-05-10 | Wyeth | CYCLOALKYL[b][1,4]DIAZEPINO[6,7,1-hi]INDOLES AND DERIVATIVES |
ATE280170T1 (de) | 2000-11-03 | 2004-11-15 | Wyeth Corp | Cyclopenta(b)(1,4) diazepino(6,7,1-hi)indole als 5ht2c antagonisten |
AR031198A1 (es) | 2000-11-03 | 2003-09-10 | Wyeth Corp | Procedimiento para la preparacion de derivados de ciclopenta(b)diazepino(6,7,1)indol |
SE0004245D0 (sv) | 2000-11-20 | 2000-11-20 | Pharmacia Ab | Novel compounds and their use |
GB0030710D0 (en) | 2000-12-15 | 2001-01-31 | Hoffmann La Roche | Piperazine derivatives |
IL156261A0 (en) | 2000-12-20 | 2004-01-04 | Bristol Myers Squibb Co | Pyrroloquinoline and pyridoquinoline derivatives and pharmaceutical compositions containing the same |
US6849619B2 (en) | 2000-12-20 | 2005-02-01 | Bristol-Myers Squibb Company | Substituted pyridoindoles as serotonin agonists and antagonists |
EP1343791A2 (en) | 2000-12-20 | 2003-09-17 | Bristol-Myers Squibb Company | Substituted tetracyclic pyridoindoles as serotonin agonists and antagonists |
AU2002338333A1 (en) | 2001-04-04 | 2002-10-21 | Wyeth | Methods for treating hyperactive gastric motility |
JP2005501092A (ja) | 2001-08-06 | 2005-01-13 | ファルマシア・アンド・アップジョン・カンパニー | 治療上有用な四環リガンド |
WO2003033497A1 (en) | 2001-10-18 | 2003-04-24 | Pharmacia & Upjohn Company | Tetracyclic azaindoles and -indolines having serotonin 5-ht2c activity |
TWI312781B (en) | 2002-04-25 | 2009-08-01 | [1,4]diazepino[6,7,1-ij]quinoline derivatives as antipsychotic and antiobesity agents | |
TW200307682A (en) | 2002-04-25 | 2003-12-16 | Wyeth Corp | 1,2,3,4,7,8-Hexahydro-6H-[1,4]diazepino[6,7,1-ij]quinoline derivatives as antipsychotic and antiobesity agents |
TW200307540A (en) | 2002-04-25 | 2003-12-16 | Wyeth Corp | [1, 4]Diazocino[7, 8, 1-hi] indole derivatives as antipsychotic and antiobesity agents |
SE0201544D0 (sv) | 2002-05-17 | 2002-05-17 | Biovitrum Ab | Novel compounds and thier use |
WO2004072046A2 (en) | 2003-02-12 | 2004-08-26 | Carex S.A. | Quinoline derivatives and their use for modulation of lxr activity |
ATE457308T1 (de) | 2003-04-21 | 2010-02-15 | Lilly Co Eli | Substituierte benzopyrane als selektive antagonisten am östrogenrezeptor-beta |
US20040235856A1 (en) | 2003-04-25 | 2004-11-25 | Pfizer Inc | Treatment of incontinence |
EP1670454A1 (en) | 2003-09-04 | 2006-06-21 | H. Lundbeck A/S | The combination of a serotonin reuptake inhibitor and loxapine |
EP2400300A1 (en) | 2004-08-25 | 2011-12-28 | Takeda Pharmaceutical Company Limited | Method of screening preventives/remedies for stress urinary incontinence |
AR052227A1 (es) | 2004-11-05 | 2007-03-07 | Wyeth Corp | Metabolitos derivados de [1,4] diazepin [ 6,7,1-ij] quinolina, metodos de preparacion y usos de los mismos |
AR051946A1 (es) | 2004-11-05 | 2007-02-21 | Wyeth Corp | Formulaciones de derivados de [1,4] diazepina [6,7,1-ij] quinolina |
GT200500317A (es) | 2004-11-05 | 2006-10-27 | Proceso para preparar compuestos de quinolina y productos obtenidos de los mismos | |
EP1714963A1 (en) | 2005-04-19 | 2006-10-25 | IPCA Laboratories Limited | Process for the Preparation of Valsartan and its Intermediates |
AR054849A1 (es) | 2005-07-26 | 2007-07-18 | Wyeth Corp | Diazepinoquinolinas, sintesis de las mismas, e intermediarios para obtenerlas |
AR056695A1 (es) | 2005-10-17 | 2007-10-17 | Wyeth Corp | Tetrahidroquinolinas, su sintesis e intermediarios |
TW200734334A (en) | 2006-01-13 | 2007-09-16 | Wyeth Corp | Treatment of substance abuse |
CA2645099A1 (en) | 2006-03-24 | 2007-10-04 | Wyeth | Methods for modulating bladder function |
TW200806321A (en) | 2006-03-24 | 2008-02-01 | Wyeth Corp | New therapeutic combinations for the treatment or prevention of psychotic disorders |
BRPI0709146A2 (pt) | 2006-03-24 | 2011-06-28 | Wyeth Corp | métodos para tratar distúrbios cognitivos e outros distúrbios |
KR20080110759A (ko) | 2006-03-24 | 2008-12-19 | 와이어쓰 | 통증 치료 |
BRPI0709159A2 (pt) | 2006-03-24 | 2011-06-28 | Wyeth Corp | combinações terapêuticas para o tratamento de depressão |
CL2008002777A1 (es) | 2007-09-21 | 2010-01-22 | Wyeth Corp | Metodo de preparacion de compuestos diazepinoquinolinicos quirales por recristalizacion en un sistema de solvente ternario. |
-
2006
- 2006-07-19 AR ARP060103086A patent/AR054849A1/es unknown
- 2006-07-24 BR BRPI0614154-4A patent/BRPI0614154A2/pt not_active Application Discontinuation
- 2006-07-24 TW TW095126932A patent/TW200738713A/zh unknown
- 2006-07-24 RU RU2008102884/04A patent/RU2008102884A/ru not_active Application Discontinuation
- 2006-07-24 EP EP06788294A patent/EP1907390A2/en not_active Withdrawn
- 2006-07-24 PE PE2006000891A patent/PE20070238A1/es not_active Application Discontinuation
- 2006-07-24 JP JP2008524026A patent/JP2009502925A/ja not_active Withdrawn
- 2006-07-24 MX MX2008001030A patent/MX2008001030A/es not_active Application Discontinuation
- 2006-07-24 KR KR1020087004478A patent/KR20080030682A/ko not_active Application Discontinuation
- 2006-07-24 US US11/491,590 patent/US7671196B2/en not_active Expired - Fee Related
- 2006-07-24 CN CNA2006800341809A patent/CN101268076A/zh active Pending
- 2006-07-24 AU AU2006276010A patent/AU2006276010A1/en not_active Abandoned
- 2006-07-24 WO PCT/US2006/028655 patent/WO2007016029A2/en active Application Filing
- 2006-07-24 CA CA002616161A patent/CA2616161A1/en not_active Abandoned
- 2006-07-24 GT GT200600326A patent/GT200600326A/es unknown
- 2006-07-26 SA SA06270241A patent/SA06270241B1/ar unknown
-
2008
- 2008-01-17 CR CR9670A patent/CR9670A/es not_active Application Discontinuation
- 2008-01-21 IL IL188896A patent/IL188896A0/en unknown
- 2008-01-25 NO NO20080468A patent/NO20080468L/no not_active Application Discontinuation
- 2008-01-30 EC EC2008008151A patent/ECSP088151A/es unknown
Also Published As
Publication number | Publication date |
---|---|
ECSP088151A (es) | 2008-02-20 |
JP2009502925A (ja) | 2009-01-29 |
US20070027142A1 (en) | 2007-02-01 |
CN101268076A (zh) | 2008-09-17 |
WO2007016029A3 (en) | 2007-05-18 |
AR054849A1 (es) | 2007-07-18 |
EP1907390A2 (en) | 2008-04-09 |
AU2006276010A1 (en) | 2007-02-08 |
IL188896A0 (en) | 2008-04-13 |
SA06270241B1 (ar) | 2009-09-02 |
MX2008001030A (es) | 2008-03-19 |
TW200738713A (en) | 2007-10-16 |
GT200600326A (es) | 2007-03-14 |
CR9670A (es) | 2008-07-29 |
CA2616161A1 (en) | 2007-02-08 |
RU2008102884A (ru) | 2009-09-10 |
US7671196B2 (en) | 2010-03-02 |
BRPI0614154A2 (pt) | 2011-03-15 |
WO2007016029A2 (en) | 2007-02-08 |
PE20070238A1 (es) | 2007-03-26 |
KR20080030682A (ko) | 2008-04-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20080468L (no) | Diazepinokinoliner, synteser av disse samt intermediater | |
UA107175C2 (uk) | Спосіб і сполука, призначені для одержання інгібіторів контранспортера натрій-глюкози 2 типу, варіанти | |
NO20081621L (no) | Tetrahydrokinoliner, syntese og intermediater | |
EA200801608A1 (ru) | Производные бензимидазолонкарбоновой кислоты | |
CY1109911T1 (el) | Πυρρολοβενζοδιαζεπινες | |
NO20074093L (no) | Fremgangsmater for fremstilling av glukopyranosyl-substituerte benzyl-benzenderivater og mellomprodukter derav | |
EA200970156A1 (ru) | Пиридизиноновые производные | |
EA201000642A1 (ru) | 2'-фтор-2'-дезокситетрагидроуридины в качестве ингибиторов цитидиндеаминазы | |
NO20080129L (no) | Fremgangsmate for fremstilling av dihydrokinazoliner | |
CY1110489T1 (el) | Παραγωγα ισοκινολινης | |
MX2009003834A (es) | Derivados de pirrolidina como inhibidores de iap. | |
TW200638930A (en) | Acetylene derivatives | |
SE0302232D0 (sv) | Novel Compounds | |
TW200740814A (en) | Compounds | |
ATE445593T1 (de) | Acetylenderivate | |
EA200700365A1 (ru) | Производные индол-2-карбоксамидина как антагонисты nmda рецептора | |
GB0508318D0 (en) | Organic compounds | |
ITMI20050801A1 (it) | Procedimento per la preparazione di telmisartan | |
EA200801145A1 (ru) | Спироциклические производные хиназолина в качестве ингибиторов pde7 | |
EA200801366A1 (ru) | Производные 3,6-дигидро-2-оксо-6н-1,3,4-тиадиазина | |
DK1931636T3 (da) | Isoquinoliner som IGF-1R-inhibitorer | |
ECSP088251A (es) | Diazepinoquinolinas, sintesis de las mismas, e intermediarios para obtenerlas | |
EA200801549A1 (ru) | Новые производные фенантридина в качестве антагонистов брадикинина | |
NO20081617L (no) | Metoder for fremstilling av Glutaminsyrederivater | |
NO20080553L (no) | Azinyl-3-sulfonylindazolderivater som 5-hydroksytrypyamin-6 ligander |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |